Trial of potential new COVID-19 treatment begins in UK
January 13, 2021Research and Development COVID-19, Synairgen, Vaccine
A large-scale trial of a new COVID-19 treatment to prevent severe illness in coronavirus patients has begun in the UK. …
Switzerland approves Moderna’s COVID-19 vaccine
January 13, 2021Research and Development COVID-19, Moderna, Vaccine
Moderna has announced that its COVID-19 vaccine has been authorised for use on those aged 18 or older in Switzerland. …
Novartis and BeiGene join forces to develop cancer drug tislelizumab
January 12, 2021Manufacturing and Production BeiGene, Cancer, Novartis
Novartis has signed a strategic collaboration agreement to in-license tislelizumab from BeiGene Ltd in major markets outside of China, accelerating …
Sosei Heptares and PharmEnable collaborate on neurological drug research
January 12, 2021Manufacturing and Production PharmEnable, Sosei Heptares
Sosei Group Corporation and PharmEnable, a UK drug discovery company, have joined forces to apply their respective technologies to drive …
AstraZeneca seeks EU approval for COVID-19 vaccine
January 12, 2021Manufacturing and Production AstraZeneca, COVID-19, Vaccine
AstraZeneca has applied for conditional marketing authorisation (CMA) from the EMA for its COVID-19 vaccine. CMA is used as the …
Boehringer Ingelheim and Enara Bio to collaborate on cancer immunotherapies
January 12, 2021Manufacturing and Production Boehringer Ingelheim, Cancer, Enara Bio
Boehringer Ingelheim and Enara Bio have entered into a strategic collaboration and licensing agreement to research and develop novel targeted …
Promising new treatment for drug-resistant prostate cancer
January 12, 2021Manufacturing and Production Cancer
A new experimental drug could offer a promising treatment strategy for men with advanced, drug-resistant prostate cancer, researchers have said. …
Purespring Therapeutics to appoint Richard Francis as CEO
January 11, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Purespring Therapeutics, a kidney-focused AAV gene therapy company, has announced it will appoint Richard Francis as Chief Executive Officer from …
Eli Lilly’s Alzheimer’s drug slows clinical decline in Phase II trial
January 11, 2021Sales and Marketing Alzheimer's, Eli Lilly
Eli Lilly’s donanemab has shown significant slowing of decline in a composite measure of cognition and daily function in patients …
Roche’s influenza drug Xofluza gets EU approval
January 11, 2021Sales and Marketing EC, Roche, influenza
The European Commission (EC) has approved Roche’s Xofluza (baloxavir marboxil) for the treatment of uncomplicated influenza in patients aged 12 …
MaxCyte signs licensing deal with Myeloid Therapeutics
January 11, 2021Sales and Marketing MaxCyte, Myeloid Therapeutics
MaxCyte, a global cell-based therapies and life sciences company, and Myeloid Therapeutics, a company harnessing and reprogramming myeloid cells to …
Sanofi to acquire Kymab for $1.1bn
January 11, 2021Sales and Marketing Malin, Sanofi, kymab
Sanofi is to acquire clinical-stage biopharmaceutical company Kymab for approximately $1.1 billion. In addition to this upfront sum, Paris-headquartered Sanofi …
Seven mass vaccination sites open in England
January 11, 2021Sales and Marketing COVID-19, UK, Vaccine
Seven mass vaccination centres have opened in England today as the government works to vaccinate as many people as possible …
Pharmafile.com’s top 10 news stories of the week
January 8, 2021Medical Communications
Almost all of Pharmafile.com’s most popular stories this week focused on developments in the global mission to vaccinate against COVID-19. …
Pfizer’s COVID-19 vaccine protects against variants, research shows
January 8, 2021Medical Communications COVID-19, Pfizer, Vaccine
Pfizer’s COVID-19 vaccine is effective against the two fast-spreading variants of the virus that emerged in the UK and South …
Bayer and CureVac to collaborate on COVID-19 vaccine candidate
January 8, 2021Medical Communications Bayer, COVID-19, Vaccine
Bayer is joining forces with CureVac, a biopharmaceutical company developing medicines based on messenger ribonucleic acid (mRNA), on its COVID-19 …
Birmingham research paves way for new anti-fibrotic glaucoma treatment
January 8, 2021Medical Communications Glaucoma, University of Birmingham
New research from the University of Birmingham has shown that a novel low molecular weight dextran-sulphate, ILB, could play a …
Arthritis drugs could save lives of COVID-19 patients, study finds
January 8, 2021Medical Communications COVID-19
Two drugs used to treat rheumatoid arthritis could cut COVID-19 hospital stays by as much as 10 days, and save …
NICE recommends AstraZeneca’s FORXIGA for heart failure
January 7, 2021AstraZeneca, NICE
NICE has issued a positive Final Appraisal Document (FAD) recommending AstraZeneca’s FORXIGA (dapagliflozin) as an option for treatment of symptomatic …
New COVID-19 screening hub to be established in Scotland
January 7, 2021COVID-19
A new COVID-19 drug screening and resistance hub, funded by medical research charity LifeArc and the Medical Research Council, is …
